RE 19 (Atenolol 25 mg)

Pill imprint RE 19 has been identified as Atenolol 25 mg.

Atenolol is used in the treatment of high blood pressure; anxiety; alcohol withdrawal; ventricular tachycardia; angina (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for RE 19 (Atenolol 25 mg)

Atenolol 25 mg RE 19 Front
Atenolol 25 mg RE 19 Back
Atenolol 25 mg RE 19
Atenolol
Imprint:
RE
19
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardioselective beta blockers
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC):
63304-0621
Inactive Ingredients:
magnesium carbonate
magnesium stearate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0322 Rebel Distributors Corp (repackager)
53002-1108 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)